# Drug Use Investigation Of Zyvox (Linezolid) (Regulatory Post Marketing Commitment Plan)

> **NCT00666276** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 1004 (actual)

## Conditions studied

- Staphylococcal Infections

## Interventions

- **DRUG:** linezolid (Zyvox)

## Key facts

- **NCT ID:** NCT00666276
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 1004 (ACTUAL)
- **Last updated:** 2012-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00666276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00666276, "Drug Use Investigation Of Zyvox (Linezolid) (Regulatory Post Marketing Commitment Plan)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00666276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*